Semaglutide
STEP 6
Novo Nordisk · Phase 3 · Completed · Enrollment 401
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide 2.4 mg | n/r | n/r | n/r | n/r | n/r |
| Placebo (semaglutide 2.4 mg) | 35 participants | 17 participants | 32 participants | n/r | 0 |
| Semaglutide 1.7 mg | n/r | n/r | n/r | n/r | n/r |
| Placebo (semaglutide 1.7 mg) | 18 participants | 10 participants | 22 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.